product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Phospho-MAPK Family Antibody Sampler Kit
catalog :
9910
conjugate :
nonconjugated
reactivity :
mouse, rat
application :
western blot
citations: 17
Published Application/Species/Sample/DilutionReference
  • western blot; mouse; loading ...; fig 4a
Yu Y, Shen Q, Lai Y, Park S, Ou X, Lin D, et al. Anti-inflammatory Effects of Curcumin in Microglial Cells. Front Pharmacol. 2018;9:386 pubmed publisher
  • western blot; mouse; 1:1000; loading ...; fig 6a
Su W, Zhang Y, Chen Y, Gong H, Lian Y, Peng W, et al. NLRP3 gene knockout blocks NF-?B and MAPK signaling pathway in CUMS-induced depression mouse model. Behav Brain Res. 2017;322:1-8 pubmed publisher
  • western blot; mouse; loading ...
Baumer Y, McCurdy S, Alcala M, Mehta N, Lee B, Ginsberg M, et al. CD98 regulates vascular smooth muscle cell proliferation in atherosclerosis. Atherosclerosis. 2017;256:105-114 pubmed publisher
  • western blot; rat; loading ...; fig 5
Feng W, Zhang K, Liu Y, Chen J, Cai Q, Zhang Y, et al. Apocynin attenuates angiotensin II-induced vascular smooth muscle cells osteogenic switching via suppressing extracellular signal-regulated kinase 1/2. Oncotarget. 2016;7:83588-83600 pubmed publisher
  • western blot; mouse; loading ...; fig 6b
Wang H, Zhu X, Qin L, Qian H, Wang Y. Microglia activity modulated by T cell Ig and mucin domain protein 3 (Tim-3). Cell Immunol. 2015;293:49-58 pubmed publisher
Zhang N, Liu L, Fan N, Zhang Q, Wang W, Zheng M, et al. The requirement of SEPT2 and SEPT7 for migration and invasion in human breast cancer via MEK/ERK activation. Oncotarget. 2016;7:61587-61600 pubmed publisher
He J, Liang X, Luo F, Chen X, Xu X, Wang F, et al. P53 Is Involved in a Three-Dimensional Architecture-Mediated Decrease in Chemosensitivity in Colon Cancer. J Cancer. 2016;7:900-9 pubmed publisher
Ding Y, Li Q, Xu Y, Chen Y, Deng Y, Zhi F, et al. Attenuating Oxidative Stress by Paeonol Protected against Acetaminophen-Induced Hepatotoxicity in Mice. PLoS ONE. 2016;11:e0154375 pubmed publisher
Dang N, Pang S, Song H, An L, Ma X. Inactivation of mitogen-activated protein kinase signaling pathway reduces caspase-14 expression in impaired keratinocytes. Iran J Basic Med Sci. 2016;19:28-33 pubmed
Chen Q, Tao J, Hei H, Li F, Wang Y, Peng W, et al. Up-Regulatory Effects of Curcumin on Large Conductance Ca2+-Activated K+ Channels. PLoS ONE. 2015;10:e0144800 pubmed publisher
Li K, Li Y, Ma Z, Zhao J. Crocin exerts anti-inflammatory and anti-catabolic effects on rat intervertebral discs by suppressing the activation of JNK. Int J Mol Med. 2015;36:1291-9 pubmed publisher
Qing Q, Zhang S, Chen Y, Li R, Mao H, Chen Q. High glucose-induced intestinal epithelial barrier damage is aggravated by syndecan-1 destruction and heparanase overexpression. J Cell Mol Med. 2015;19:1366-74 pubmed publisher
Bozic I, Savic D, Laketa D, Bjelobaba I, Milenkovic I, Pekovic S, et al. Benfotiamine attenuates inflammatory response in LPS stimulated BV-2 microglia. PLoS ONE. 2015;10:e0118372 pubmed publisher
Jiao Z, Li M, Feng Y, Shi J, Zhang J, Shao B. Hormesis effects of silver nanoparticles at non-cytotoxic doses to human hepatoma cells. PLoS ONE. 2014;9:e102564 pubmed publisher
Jun D, Hwang M, Kim H, Hwang S, Kim S, Lee C. Ouabain, a cardiac glycoside, inhibits the Fanconi anemia/BRCA pathway activated by DNA interstrand cross-linking agents. PLoS ONE. 2013;8:e75905 pubmed publisher
Mueller K, Kornfeld J, Friedbichler K, Blaas L, Egger G, Esterbauer H, et al. Impairment of hepatic growth hormone and glucocorticoid receptor signaling causes steatosis and hepatocellular carcinoma in mice. Hepatology. 2011;54:1398-409 pubmed publisher
Yoshizaki T, Motomura W, Tanno S, Kumei S, Yoshizaki Y, Tanno S, et al. Thiazolidinediones enhance vascular endothelial growth factor expression and induce cell growth inhibition in non-small-cell lung cancer cells. J Exp Clin Cancer Res. 2010;29:22 pubmed publisher
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
https://www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.